← Leaderboards
Mark E Lindsay
Johns Hopkins University
$4,029,571
Attributed
$5,614,817
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $904.8K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,614,817 · 4
By mechanism
R01$4,826,676 · 2
K08$402,525 · 1
R21$385,616 · 1
Top collaborators
- Patricia L Musolino4 shared
- Hongmei Mou2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard D Schulick$14,841,770
- William George Nelson$34,555,726
- Samuel R Denmeade$5,431,317
- Lori Chaffin Jordan$8,910,492
- Fabian M Johnston$3,625,375
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMutationMouse ModelPhenotypeLifeMutantFunctional DisorderIn VivoCell ModelAllelesAffectIn VitroMolecularVascular DiseasesAortic AneurysmSmooth Muscle MyocytesAortaComplexPathogenicityMediatingCellsHuman DiseaseBlood VesselsIschemic Stroke
Grant awards (15)
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2025 · NS
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2024 · NS
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2023 · NS
Targeting Chronic Senescence to Restore Tissue Homeostasis in Myhre syndrome$208,595
R21 · FY2023 · AR
Modeling and Therapeutic Approaches for Genetic Vasculopathies$696,219
R01 · FY2022 · NS
Targeting Chronic Senescence to Restore Tissue Homeostasis in Myhre syndrome$177,021
R21 · FY2022 · AR
The Role of HDAC9/MITR in the Pathogenesis of Thoracic Aortic Aneurysm (TAA)$408,360
R01 · FY2020 · HL · contact PI
The Role of HDAC9/MITR in the Pathogenesis of Thoracic Aortic Aneurysm (TAA)$408,360
R01 · FY2019 · HL · contact PI
The Role of HDAC9/MITR in the Pathogenesis of Thoracic Aortic Aneurysm (TAA)$408,360
R01 · FY2018 · HL · contact PI
The Role of HDAC9/MITR in the Pathogenesis of Thoracic Aortic Aneurysm (TAA)$408,360
R01 · FY2017 · HL · contact PI
The Role of HDAC9/MITR in the Pathogenesis of Thoracic Aortic Aneurysm (TAA)$408,360
R01 · FY2016 · HL · contact PI
Development Underpinnings of Acquired Aortic Aneurysm in Marfan Syndrome$133,875
K08 · FY2013 · HL · contact PI
Development Underpinnings of Acquired Aortic Aneurysm in Marfan Syndrome$128,548
K08 · FY2012 · HL · contact PI
Development Underpinnings of Acquired Aortic Aneurysm in Marfan Syndrome$5,777
K08 · FY2012 · HL · contact PI
Development Underpinnings of Acquired Aortic Aneurysm in Marfan Syndrome$134,325
K08 · FY2011 · HL · contact PI